Amyloid Beta Antibodies

These camelid (alpaca) IgG polyclonal antibodies were generated against brain homogenate derived from Alzheimer patient and recognize amyloid beta protein from human, mouse, and dog.

Highlights

  • Shown to recognize amyloid beta protein from human, mouse, and dog
  • Recommended for ELISA, Western blot, IHC, and IF applications

The progressive accumulation of extracellular amyloid plaques in the brain is a common hallmark of Alzheimer's disease. Forms of Amyloid beta phosphorylated at serine residue 8 have increased propensity to form toxic aggregates as compared to non-phosphorylated species.

From the laboratory of Mourad Tayebi, PhD, Western Sydney University.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EWS201
Anti-Amyloid Beta, aa 1-40 [P100] Antibody
100ug In stock
Regular Price:$299.00
On Sale:
EWS202
Anti-Amyloid Beta, aa 1-42 [P200] Antibody
100ug In stock
Regular Price:$299.00
On Sale:
Specifications

Product Type: Antibody
Accession ID: P05067.3
Antigen: Amyloid beta peptide 1-40 (P100), Amyloid beta peptide 1-42 (P200)
Molecular Weight: 4329.82 Da (P100) 4514.1 Da (P200)
Isotype: IgG
Clonality: Polyclonal
Clone Name: P100
Reactivity: human, mouse, dog
Immunogen: Brain homogenate derived from Alzheimer patient
Species Immunized: Alpaca
Method Used to Determine Concentration: BCA
Buffer: PBS
Tested Applications: ELISA (1ug/mL), Western Blot (1ug/mL), IHC (1:500), IF (1:500)
Concentration: 1mg/mL
Amount: 100ug
Comments: Brain homogenate adsorbed to immunomagnetic beads and emulsified in CFA and final booster in IFA.; References included refer to mAbs produced from the same animals the pAbs were derived from.
Storage: -20C
Shipped: Dry Ice

Data
Western blot
Prion Antibody
Provider
From the laboratory of Mourad Tayebi, PhD, Western Sydney University.
References
  1. Rusbridge C, Salguero FJ, David MA, Faller KME, Bras JT, Guerreiro RJ, Richard-Londt AC, Grainger D, Head E, Brandner SGP, Summers B, Hardy J, Tayebi M. An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers. Front Aging Neurosci. 2018 Jan 30;10:7. doi: 10.3389/fnagi.2018.00007. PMID: 29441010; PMCID: PMC5797595.
  2. David MA, Jones DR, Tayebi M. Potential candidate camelid antibodies for the treatment of protein-misfolding diseases. J Neuroimmunol. 2014 Jul 15;272(1-2):76-85. doi: 10.1016/j.jneuroim.2014.05.001. Epub 2014 May 10. PMID: 24864011.

If you publish research with this product, please let us know so we can cite your paper.

Loading...